You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

Details for Patent: 8,642,600


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,642,600
Title:Method of treating autism
Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT.sub.1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): ##STR00001## wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
Inventor(s): Jordan; Shaun (Germantown, MD), Kikuchi; Tetsuro (Tokushima, JP), Tottori; Katsura (Kamiita-cho, JP), Hirose; Tsuyoshi (Tokushima, JP), Uwahodo; Yasufumi (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:13/185,879
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,642,600

Introduction to Patent 8,642,600

United States Patent 8,642,600, titled "Method of treating autism," is a patent that outlines a specific method for treating disorders of the central nervous system, particularly those associated with certain receptor subtypes. Here, we will delve into the key components of this patent, including its scope, claims, and the broader patent landscape.

Patent Structure and Components

Document Number and Type

The patent number, US8642600B2, indicates that this is a U.S. patent with a previously published application, as denoted by the "B2" code[1].

Title and Abstract

The title of the invention is "Method of treating autism," and the abstract provides a brief, non-technical description of the method. This abstract is crucial for understanding the general purpose and scope of the patent[1].

Field of Search and Classifications

The patent includes classifications such as IPC (International Patent Classification) and national classifications. For example, the national classification might include codes that specify the technical field, such as those related to medical treatments or neurological disorders[1].

Inventors, Applicants, and Assignees

The patent lists the inventors, the applicant (the person or organization that filed the application), and the assignee (the owner of the patent at the time it was issued). These details are essential for understanding the ownership and development history of the patent[1].

Claims: The Heart of the Patent

Definition and Purpose

The claims section is the most critical part of the patent, as it defines the scope of protection. Claims are paragraphs located at the end of the specification that begin with phrases like “I claim” or “What is claimed.” These claims outline the legal boundaries of the invention, similar to how a property deed defines physical boundaries[1].

Claim Construction

Claim 1 of the '600 patent, like other claims, would be constructed to clearly define what is being patented. This involves a detailed description of the method, including any specific steps, materials, or conditions necessary for the treatment. Claim construction is a critical process in patent litigation, as it determines the scope of the patent's protection[5].

Number and Complexity of Claims

While a patent must have at least one claim, most patents, including the '600 patent, typically have multiple claims. These claims can range from independent claims that stand alone to dependent claims that refer back to other claims. The complexity and number of claims can vary significantly, with some patents having hundreds of claims[1].

Specification and Drawings

Detailed Description

The specification is a written description of the invention that includes a discussion of related prior art, a description of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. This section must provide enough detail so that anyone with ordinary skill in the same technical field can understand and replicate the invention[1].

Drawings

The drawings section contains black and white drawings that illustrate the technical details of the invention. While drawings are not required for all types of inventions (e.g., process or method patents), they are often crucial for understanding complex technical aspects of the invention[1].

Prior Art and Field of Search

Prior Art References

The patent includes references to U.S. and foreign patent documents and other publications cited as related prior art by the inventor and the patent examiner. This section helps in understanding the existing knowledge in the field and how the current invention differs from or builds upon previous work[1].

Field of Search

The field of search section lists the classifications consulted by the patent examiner during the prior art search. This information is valuable for understanding the breadth of the search and the relevance of the prior art cited[1].

Patent Landscape and Litigation

Related Patents

The '600 patent is part of a larger portfolio of patents related to the treatment of central nervous system disorders. Other patents, such as U.S. Patent Nos. 5,006,528, 7,053,092, 8,017,615, 8,580,796, 8,642,760, and 8,759,350, are often cited together in litigation and regulatory filings. These patents collectively protect various aspects of the treatment methods and compounds involved[5].

Litigation Examples

Cases like Otsuka Pharm. Co. v. Zydus Pharms. U.S. & Cadila Healthcare Ltd. and Otsuka Pharm. Co. v. Torrent Pharms. Ltd. illustrate how these patents are used in litigation. These cases often involve claims of direct and induced infringement, where the patent holder seeks to protect their intellectual property rights against generic or competing products[2][5].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those related to medical treatments. This dataset can be used to analyze trends in patent scope and the complexity of claims over time, offering insights into the evolving landscape of medical patenting[3].

Patent Scope Measurements

Research papers like "Patent Claims and Patent Scope" by Marco, Sarnoff, and deGrazia discuss the measurements of patent scope and how they are derived from parsed claims text. These studies help in understanding the breadth and depth of patent protection in various fields, including medical treatments[3].

Key Takeaways

  • Claims Define Protection: The claims section is crucial as it legally defines the scope of the patent.
  • Detailed Specification: The specification must provide enough detail for anyone with ordinary skill in the field to understand and replicate the invention.
  • Prior Art and Field of Search: Understanding prior art and the field of search helps in contextualizing the invention within existing knowledge.
  • Litigation and Patent Landscape: The '600 patent is part of a broader portfolio of related patents, and its protection is often enforced through litigation.
  • Economic and Research Implications: Analyzing patent claims and scope can provide valuable insights into the evolving medical patent landscape.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The claims section defines the legal boundaries of the invention, specifying what is protected by the patent.

Q: Why are drawings important in a patent? A: Drawings illustrate the technical details of the invention, making it easier to understand complex aspects.

Q: How does prior art impact the patent application process? A: Prior art references help in understanding existing knowledge and ensuring the invention is novel and non-obvious.

Q: What is the significance of the field of search in a patent? A: The field of search indicates the classifications consulted during the prior art search, showing the breadth of the search.

Q: How are patents like the '600 patent used in litigation? A: These patents are used to protect intellectual property rights against infringement, often involving claims of direct and induced infringement.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Casetext.com: Otsuka Pharm. Co. v. Zydus Pharms. U.S. & Cadila Healthcare Ltd.
  3. USPTO.gov: Patent Claims Research Dataset - USPTO.
  4. Patents.google.com: US8642600B2 - Method of treating autism - Google Patents.
  5. Case-law.vlex.com: Otsuka Pharm. Co. v. Torrent Pharms. Ltd., Civil Action No. 14-1078.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,642,600

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.